Lars Rebien Sørensen
Director/Board Member presso THERMO FISHER SCIENTIFIC
Patrimonio netto: 5 M $ in data 31/03/2024
Provenienza dei contatti di primo grado di Lars Rebien Sørensen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Medical Specialties | 123 | |
114
| Public Company | Pharmaceuticals: Major | 114 |
| Private Company | Movies/Entertainment | 45 | |
Copenhagen Business School
38
| College/University | Other Consumer Services | 38 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
34
| Extinct | Pharmaceuticals: Major | 34 |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark.
28
| Foundation/Endowment | Investment Trusts/Mutual Funds | 28 |
University of Copenhagen
26
| College/University | Other Consumer Services | 26 |
24
| Public Company | Electric Utilities | 24 |
| Public Company | Beverages: Alcoholic | 22 | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.
19
| Subsidiary | Miscellaneous | 19 |
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark.
11
| Subsidiary | Beverages: Alcoholic | 11 |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland.
9
| Private Company | Pharmaceuticals: Major | 9 |
Novo Nordisk (Private Equity)
 Novo Nordisk (Private Equity) Investment ManagersFinance Novo Nordisk A/S (CO: NOVO.B; NYSE: NVO), a Danish healthcare company which manufactures and markets pharmaceutical products and services worldwide, invests through their corporate venture fund NNBF-Novo Nordisk Biotech Fund (NNBF). Based in Bagsværd near Copenhagen, NNBF is a business unit within Novo Nordisk A/S, responsible for the company's venture capital activities. Investments are made on the books of Novo Nordisk A/S out of internal financial resources. NNBF is managed as an evergreen fund.
3
| Extinct | Investment Managers | 3 |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets.
3
| Operating Division | Financial Conglomerates | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Lars Rebien Sørensen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ALERE INC | Medical Specialties | Corporate Officer/Principal President | |
| NESTLÉ S.A. | Food: Major Diversified | Chief Operating Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| DANSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member Director/Board Member President | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| RTL GROUP S.A. | Broadcasting | Chief Executive Officer Director/Board Member Director/Board Member | |
| AP MOLLER MAERSK | Marine Shipping | Corporate Officer/Principal Director of Finance/CFO | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SCHLUMBERGER AG | Beverages: Alcoholic | Director/Board Member Chairman | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| State University of New York at Buffalo | College/University | Doctorate Degree Doctorate Degree | |
| University of Kiel | College/University | Doctorate Degree Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| University of Aarhus | College/University | Graduate Degree Director/Board Member Graduate Degree Graduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Medical/Nursing ServicesHealth Services Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member | |
| The Danish Academy of Technical Sciences | College/University | Director/Board Member President | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President Director of Finance/CFO President | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Corporate Officer/Principal Chief Executive Officer | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NNIT A/S | Information Technology Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor | |
Moelis & Co. (UK) LLP
 Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The private company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Bertelsmann Management SE
 Bertelsmann Management SE Miscellaneous Commercial ServicesCommercial Services Bertelsmann Management SE is an international media enterprise with corporate divisions including RTL Group, Penguin Random House, and Gruner + Jahr. The private company is based in Gütersloh, DE and has a global presence of subsidiaries in several regions. The German company's Press Center provides detailed information for journalists, and the company is also committed to Corporate Responsibility activities. Thomas Hermann Rabe has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
Ferring Pharmaceuticals Ltd.
 Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
Ferring Laboratories Ltd.
 Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The private company is based in Middlesex, UK and was founded in 1980. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
Carlsberg Byen P/S
 Carlsberg Byen P/S Real Estate DevelopmentFinance Carlsberg Byen P/S engages in real estate development. It develops residential, commercial, retail, culture, sport, and institutions. The company was founded on August 2013 and is headquartered in Copenhagen, Denmark. | Real Estate Development | Director/Board Member Director/Board Member | |
Axcelfuture
 Axcelfuture Financial ConglomeratesFinance Axcelfuture engages in investment services. The company was founded by Povl Christian Lütke Frigast and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| CONVATEC GROUP PLC | Medical Specialties | Director/Board Member Director/Board Member | |
Ferring Pharmaceuticals SA
 Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Biotechnology | Director/Board Member President Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
FinVector Oy
 FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The private company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Trizell Holding SA | Director/Board Member Founder | ||
Ferring GmbH
 Ferring GmbH Pharmaceuticals: MajorHealth Technology Ferring GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Kiel, Germany. The company was founded in 1990. The CEO is Claus Tollnick. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Danimarca | 17 |
| Stati Uniti | 14 |
| Regno Unito | 8 |
| Svizzera | 4 |
| Francia | 4 |
Settori
| Health Technology | 21 |
| Consumer Services | 13 |
| Finance | 7 |
| Consumer Non-Durables | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 685 |
| Chairman | 200 |
| Corporate Officer/Principal | 194 |
| Independent Dir/Board Member | 149 |
| Chief Executive Officer | 80 |
Contatti più connessi
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Göran Albert Ando | 44 |
| Scott Sperling | 40 |
| Jørn Peter Jensen | 37 |
| Thomas Hermann Rabe | 33 |
| Sten Scheibye | 31 |
| Hélène Ploix | 31 |
| Bodo Knut Uebber | 30 |
| Nanna Liebach Lüneborg | 29 |
| Lilian Biner | 29 |
| Douglas Williams | 25 |
| Bruce Carter | 25 |
| Sylvie Grégoire | 25 |
| Thomas Dyrberg | 24 |
| Steen Riisgaard | 24 |
- Borsa valori
- Insiders
- Lars Rebien Sørensen
- Connessioni Società
